An improved gas chromatography screening method for doping substances using triple quadrupole mass spectrometry, with an emphasis on quality assurance

Biomedical Chromatography

Volumn 26, Issue 11, 2012, Pages 1416-1435

  De Brabanter, Nik ^a   Van Gansbeke, Wim ^a   Geldof, Lore ^a   Van Eenoo, Peter ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Doping; Measurement uncertainty; Microbiological degradation; Minor metabolites; Urine

Indexed keywords

BIOMOLECULES; EFFICIENCY; GAS CHROMATOGRAPHY; LIPIDS; MASS SPECTROMETRY; QUALITY ASSURANCE; QUALITY CONTROL; UNCERTAINTY ANALYSIS;

ANDROSTANE; DOPING SUBSTANCES; ENDOGENOUS STEROIDS; GC-QQQ-MS; MEASUREMENT UNCERTAINTY; MICROBIOLOGICAL DEGRADATION; MINOR METABOLITE; SCREENING METHODS; TRIPLE-QUADRUPOLE MASS SPECTROMETRY; URINE;

METABOLITES;

5BETA ANDROSTANE DERIVATIVE; 5BETA ANDROSTANEDIONE; ANDROSTANEDIONE; BOLASTERONE; EPITESTOSTERONE; ESMOLOL; ETIOCHOLANOLONE; FENOTEROL; MORPHINE; OXYCODONE; PETHIDINE; PRASTERONE; SALBUTAMOL; STEROID; UNCLASSIFIED DRUG; ZERANOL;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); DEGRADATION; DERIVATIZATION; DOPING; DRUG SCREENING; GAS CHROMATOGRAPHY; HUMAN; HYDROLYSIS; LIMIT OF DETECTION; NORMAL HUMAN; QUADRUPOLE MASS SPECTROMETRY; QUALITY CONTROL; RELIABILITY; STANDARD; TRIPLE QUADRUPOLE MASS SPECTROMETRY;

CANNABIS;

EID: 84867143700     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2714     Document Type: Article

References (29)

1. Baume N, Steel G, Edwards T, Thorstensen E and Miller BF. No variation of physical performance and perceived exertion after adrenal gland stimulation by synthetic ACTH (Synacthen®) in cyclists. European Journal of Applied Physiology 2008; 104: 589-600.
2. Botre F, Mazzarino M and Orengia M. Application of fast gas chromatography/mass spectrometry for the rapid screening of synthetic anabolic steroids and other drugs in anti-doping analysis. Rapid Communications in Mass Spectrometry 2007; 21: 4117-4124.
3. Bowers LD. Analytical advances in detection of performance-enhancing compounds. Clinical Chemistry 1997; 43: 1299-1304.
4. Castillo B, Bansal V, Ganesan A, Halling P, Secundo F, Ferrer A, Griebenow K and Barletta G. On the activity loss of hydrolases in organic solvents: II. a mechanistic study of subtilisin Carlsberg. BMC Biotechnology 2006; 6: 51.
5. Cawley AT, Hine ER, Trout GJ, George AV and Kazlauskas R. Searching for new markers of endogenous steroid administration in athletes: 'looking outside the metabolic box'. Forensic Science International 2004; 143: 103-114.
6. Cawley AT, Trout GJ, Kaziauskas R and George AV. The detection of androstenedione abuse in sport: a mass spectrometry strategy to identify the 4-hydroxyandrostenedione metabolite. Rapid Communications in Mass Spectrometry 2008; 22: 4147-4157.
7. de la Torre R, de la Torre X, Alia C, Segura J, Baro T and Torres-Rodriguez JM. Changes in androgenic steroid profile due to urine contamination by microorganisms: a prospective study in the context of doping control. Analytical Biochemistry 2001; 289: 116-123.
8. Faber NM. Regulations in the field of residue and doping analysis should ensure the risk of false positive declaration is well-defined. Accreditation and Quality Assurance 2009; 14: 111-115.
9. Fragkaki AG, Angelis YS, Tsantili-Kakoulidou A, Koupparis M and Georgakopoulos C. Statistical analysis of fragmentation patterns of electron ionization mass spectra of enolized-trimethylsilylated anabolic androgenic steroids. International Journal of Mass Spectrometry 2009; 285: 58-69.
10. Galesio M, Rial-Otero R, Simal-Gandara J, de la Torre X, Botre F and Capelo-Martinez JL. Improved ultrasonic-based sample treatment for the screening of anabolic steroids by gas chromatography/mass spectrometry. Rapid Communications in Mass Spectrometry 2010; 24: 2375-2385.
11. General Assembly of the World Medical Association. Ethical Principles for Medical Research Involving Human Subjects. World Medical Association Declaration of Helsinki, 2008.
12. Hoffmann E and Stroobant V. Mass Spectrometry: Principles and Applications. Wiley: Chichester, 2007.
13. ILAC. Introducing the Concept of Uncertainty of Measurement in Testing in Association with the Application of the Standard ISO/IEC 17025. International Laboratory Accreditation Cooperation, 2002; 7.
14. Kiousi P, Angelis YS, Lyris E, Koupparis M, Calokerinos AC, Atta-Politou J and Georgakopoulos CG. Two-step silylation procedure for the unified analysis of 190 doping control substances in human urine samples by GC-MS. Bioanalysis 2009; 1: 1209-1224.
15. Lévesque JF and Ayotte C. Criteria for the Detection of Androstenedione Oral Administration, 7th Cologne Workshop on Dope Analysis, Cologne. Sport und Buch Strauß, 1999a.
16. Lévesque JF and Ayotte C. The Oral Administration of DHEA: the Efficiency of Steroid Profiling. Proceedings of the 7th Cologne Workshop on Dope analysis, Cologne. Sport und Buch Strauß, 1999b.
17. Marcos J, Pascual JA, de la Torre X and Segura J. Fast screening of anabolic steroids and other banned doping substances in human urine by gas chromatography/tandem mass spectrometry. Journal of Mass Spectrometry 2002; 37: 1059-1073.
18. Mareck U, Geyer H, Opfermann G, Thevis M and Schanzer W. Factors influencing the steroid profile in doping control analysis. Journal of Mass Spectrometry 2008; 43: 877-891.
19. Mazzarino M, Orengia M and Botre F. Application of fast gas chromatography/mass spectrometry for the rapid screening of synthetic anabolic steroids and other drugs in anti-doping analysis. Rapid Communications in Mass Spectrometry 2007; 21: 4117-4124.
20. Mazzarino M, Abate MG, Alocci R, Rossi F, Stinchelli R, Molaioni F, de la Torre X and Botre F. Urine stability and steroid profile: towards a screening index of urine sample degradation for anti-doping purpose. Analytica Chimica Acta 2011; 683: 221-226.
21. Munoz-Guerra J, Carreras D, Soriano C, Rodriguez C and Rodriguez AF. Use of ion trap gas chromatography-tandem mass spectrometry for detection and confirmation of anabolic substances at trace levels in doping analysis. Journal of Chromatography. B, Biomedical Sciences and Applications 1997; 704: 129-141.
22. Tsivou M, Livadara D, Georgakopoulos DG, Koupparis MA, Atta-Politou J and Georgakopoulos CG. Stabilization of human urine doping control samples: II. Microbial degradation of steroids. Analytical Biochemistry 2009; 388: 146-154.
23. Van Eenoo P, Van Gansbeke W, De Brabanter N, Deventer K and Delbeke FT. A fast, comprehensive screening method for doping agents in urine by gas chromatography-triple quadrupole mass spectrometry. Journal of Chromatography. A 2011; 21: 3306-3316.
24. Van Renterghem P, Van Eenoo P, Van Thuyne W, Geyer H, Schanzer W and Delbeke FT. Validation of an extended method for the detection of the misuse of endogenous steroids in sports, including new hydroxylated metabolites. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2008; 876: 225-235.
25. Van Renterghem P, Van Eenoo P, Geyer H, Schanzer W and Delbeke FT. Reference ranges for urinary concentrations and ratios of endogenous steroids, which can be used as markers for steroid misuse, in a Caucasian population of athletes. Steroids 2010; 75: 154-163.
26. WADA. WADA Technical Document - TD2004EAAS. WADA: Montreal, 2004; 11.
27. WADA. WADA Technical Document - TD2010IDCR. Identification criteria for qualitative assays incorporation column chromatography and mass spectometry. WADA: Montreal, 2010a.
28. WADA. WADA Technical Document - TD2010MRPL. WADA: Montreal, 2010b.
29. WADA. The 2011 Prohibited List, International Standard. WADA: Montreal, 2011.